tri-CAR T-cell therapy (ImmunoACT)

N/A

Report date: 2025/06/11 11:02:31

Base Information

Drug Nametri-CAR T-cell therapy (ImmunoACT)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocytes stimulantsImmunostimulants

TargetsUpdating

Therapy Area/IndicationsLymphomaLeukemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIndia

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCaring Cross

China Registration ClassN/A

Develop Information

Active CompaniesImmunoadoptive Cell Therapy Pvt Ltd

Inactive CompaniesCaring Cross

Active IndicationsLymphomaLeukemia

Inactive IndicationsN/A

Other Information

ATC CodeN/A